Definition, applicable materials, and service boundaries
Sleep clinical sample cold-chain logistics is the controlled movement of human specimens among collection sites, processing laboratories, central laboratories, and biobanks according to the protocol, specimen type, and target analyte. Within WSIC 6.5.2, materials may include whole blood, serum, plasma, saliva, urine, stool, swabs, cells, or isolated products. Deliverables include transport specifications, packaging systems, lane qualification, carrier oversight, temperature monitoring, tracking, receipt confirmation, deviation investigation, and quality reporting, with defined conditions, time limits, and handoffs.
“Cold chain” does not mean freezing every specimen and is not another name for expedited delivery. The fit condition may be controlled ambient, refrigerated, frozen, ultra-low, or vapor-phase nitrogen, as determined by analyte stability, tube additives, processing state, and assay. The service differs from the preceding entry on gut microbiome sample management, the next entry on outsourced sample testing, on-site collection and centrifugation, long-term biobank storage, and dangerous-goods consulting. Transport cannot repair precollection or processing errors or guarantee that every specimen will be testable, valid, or useful to the study.
Collection timing, stability, and transport specifications
Before dispatch, the testing purpose should become a specimen specification covering matrix, collection device and additives, volume, mixing, clotting, centrifugation, aliquoting, light protection, allowable hold time, target temperature, freeze–thaw limits, minimum residual volume, and receipt criteria. Transport conditions need stability evidence for the particular assay and analyte; another laboratory’s practice or a different biomarker is not sufficient. A change in tube, stabilizer, lane, package, equipment, or assay platform should be assessed for effects on recovery, degradation, hemolysis, contamination, and result shift.
Sleep studies must also preserve biological timing. Melatonin, cortisol, pharmacokinetic, inflammatory, metabolic, and other measures may depend on clock time, time relative to sleep or waking, light exposure, meals, posture, activity, medication, and actual sleep. Labels and accompanying data should record the protocol-defined collection time, time zone, and critical conditions; “morning sample” is not an analyzable time definition. Transport delay and mistimed collection are different sources of bias and should be recorded separately. Correct shipment temperature does not establish correct collection timing.
Identity, aliquots, and chain of custody
Each primary container and aliquot should carry a unique, low-temperature-durable, machine-readable identifier linked to study, coded participant, visit, time point, specimen type, aliquot, and status, without exposing unnecessary identity on the outer package. Before packing, staff should reconcile the manifest against actual tubes, volume, seals, label readability, processing completion time, and freeze–thaw history. Duplicate identifiers, missing labels, damaged containers, and out-of-protocol specimens require segregation and escalation. Electronic and paper contingencies should use consistent identifiers, units, and time formats, and manual relabeling should preserve the original value, reason, and actor.
Chain-of-custody records should capture the person, date and time, location, container condition, temperature device, and tracking number at collection, processing, interim storage, retrieval, packing, carrier tender, transfer, customs, delivery, and laboratory accession. Carrier scans prove package movement, not specimen identity or custody. Seal, access, dual-check, and witness requirements should be proportional to study risk. In blinded studies, treatment information should remain separate from routine logistics labels, while an emergency identification mechanism protects handlers without disclosing assignment during normal operations.
Classification, packaging, and dangerous-goods compliance
A competent shipper should classify material using known or reasonably suspected pathogen risk, culture status, specimen properties, and mode, and then check current requirements at origin, destination, transit states, airlines, and ground carriers. A clinical-trial origin does not make infection risk absent, and every human specimen should not be assigned the highest hazard class. Classification, UN number, proper shipping name, documentation, marks, and labels should agree, and function-specific training and qualifications should remain current.
Where applicable, packaging uses a leakproof primary receptacle, absorbent and cushioning material, a leakproof secondary receptacle, and a sufficiently strong outer package, accounting for liquid volume, pressure, low-temperature embrittlement, and sharps. Refrigerant belongs in the correct layer and must not damage specimens directly. Dry ice sublimates, so the outer package must permit gas release and display the required net quantity rather than becoming a sealed pressure vessel. Dry nitrogen shippers, lithium-powered loggers, and other dangerous goods each require separate checks. Compliant packaging protects people and the environment but does not itself prove temperature control or specimen quality.
Package qualification, temperature monitoring, and lane validation
The packaging system should be qualified under expected worst cases for load, void space, refrigerant conditioning and placement, high and low ambient temperature, season, transit duration, delay, opening, vibration, drop, and package reuse. Qualification should yield executable packing configurations for different loads and lanes, not a single ideal test report. Refrigerant should not be increased by guesswork; overcooling can freeze and damage a refrigerated specimen. Changes to packaging, refrigerant, data logger, or supplier enter controlled reevaluation.
Temperature loggers need traceable calibration or performance confirmation, with range, accuracy, interval, response time, battery, and low-temperature suitability matched to risk and placement representative of specimen exposure. Before dispatch, staff should start the logger and reconcile its identifier and clock. At receipt, the raw file, graph, reader, software version, and reviewer should be retained. A single indicator answers only its designed question, and outside ambient temperature does not represent the specimen. A missing, unstarted, or out-of-range logger is an evidence gap, not automatic release because no excursion was seen.
Lane operations, cross-border movement, and continuity
The shipping plan should confirm address, contact, business days and holidays, receiving capacity, air or ground cutoffs, expected duration, transfer points, customs, and permits, with delay margin. Carriers should offer traceability and the required dangerous-goods and temperature-control capability. Service agreements define pickup, conditions prohibiting opening or repacking, authority to replenish refrigerant, status messages, escalation, returns, and incident reporting. Weekend arrival, absent receivers, address errors, and lack of temperature-controlled holding space should be removed before release rather than discovered at destination.
Contingency plans should cover canceled flights, customs holds, extreme weather, vehicle failure, refrigerant depletion, package damage, leakage, logger alarms, and receiving-site power failure, with round-the-clock contacts, alternate lanes, safe isolation, and rules on refrigerant replenishment. Cross-border work also requires review of human-specimen, infectious-substance, dry-ice, import and export, ethics consent, material-transfer, privacy, and human-genetic-resource controls. Logistical feasibility is not legal authorization. Permits, filings, and receiving-laboratory confirmation should precede release; splitting, renaming, or misdeclaring shipments cannot be used to evade controls.
Receipt, deviation disposition, and quality claims
Receiving staff should inspect seals, appearance, tube count, identity, temperature records, remaining refrigerant, arrival time, and documents, recording the interval from opening to storage or testing and applying predefined accept, quarantine, or reject criteria. For any temperature excursion, delay, breakage, leak, label mismatch, count discrepancy, or suspected thaw, the sample and evidence should first be preserved. An authorized laboratory or scientific lead then determines disposition using stability, duration, extreme value, sample position, and intended test. A carrier cannot erase a deviation merely by recooling the shipment.
The quality system should trend on-time delivery, temperature-evidence completeness, damage, rejection, recollection, and investigation duration by site, lane, season, package, carrier, and specimen type, followed by root cause, corrective and preventive action, and effectiveness review for recurring issues. Reports should state actual conditions, deviations, disposition rationale, and remaining limitations. “End-to-end cold chain” is supportable only with complete traceable records. Successful transport does not prove perfect analyte stability, correct test results, or representative sampling, and public claims should not promise zero excursion, zero degradation, or any sleep-medicine conclusion.